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Abstract
Background: A description of the diagnostic features of Miller Fisher syndrome.
Case presentation: The clinical presentation, investigation, and subsequent progress of our
patient with clinical unilateral external ophthalmoplegia.
Conclusion:  Our case demonstrates the presentation of clinical unilateral external
ophthalmoplegia as part of the full triad of Miller Fisher syndrome.
Background
Miller Fisher syndrome was originally described in 1956
as a triad of total external ophthalmoplegia, ataxia and
loss of tendon reflexes [1]. Since the original description
acute phase immunoglobulin G (IgG) antibodies to
GQ1b ganglioside have been recognised as a serum
marker for Miller Fisher syndrome [2]. Anti GQ1b IgG
antibodies are found in over 90% of cases of Miller Fisher
syndrome and are highly disease specific [3]. We report a
case of a 32-year old gentleman with clinical unilateral
external ophthalmoplegia in Miller Fisher syndrome con-
firmed by positive GQ1b antibody titre.
Case presentation
A 32-year old gentleman presented to the ophthalmic
accident and emergency department with a four-day his-
tory of worsening horizontal and vertical diplopia. He
denied any other ophthalmic or neurological symptoms
at presentation. Other than a recent mild coryzal illness he
was fit and well. He had no significant past ocular or med-
ical history and took no regular medications.
Ocular examination within the accident and emergency
department showed a one-millimetre ptosis of the left
upper lid, with limitation of left ocular movements in all
directions of gaze. Right ocular movements were full. The
remainder of the ocular and cranial nerve examination
was normal. Eye movement testing showed a -2/-3 reduc-
tion in left ocular movements in all directions of gaze,
with an associated +2 over-action in the corresponding
right ocular movements. Figure 1 shows the Hess chart
recorded at presentation.
A CT scan of his head with contrast showed no abnormal-
ity and the patient was transferred to the regional neuro-
sciences centre for further investigation where the patient
was found to be ataxic on heel to toe walk and the deep
tendon reflexes were absent. Further investigation includ-
ing an MRI, serology, lumbar puncture and Tensilon test
were normal. Anti GQ1b IgG antibodies were positive
with a significant titre by laboratory reference range, con-
firming the clinical diagnosis of Miller Fisher syndrome.
With conservative management the patient's signs and
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symptoms resolved spontaneously within five weeks of
presentation, leaving no permanent sequelae.
Conclusion
The marked asymmetry of the ophthalmoplegia in this
case is unusual, and to our knowledge only a single previ-
ous report of a clinical unilateral external ophthalmople-
gia as part of the full triad of Miller Fisher syndrome has
been documented within the literature [4]. Acute partial
bilateral and unilateral ophthalmoparesis has been docu-
mented in association with anti GQ1b IgG antibodies,
however these patients were not ataxic and the presence of
deep tendon reflexes were variable [5], or neurological
examination was normal [6].
This case demonstrates that uniocular external ophthal-
moplegia can occur as part of the full triad in Miller Fisher
syndrome. This reinforces the importance of considering
systemic autoimmune diseases normally associated with
bilateral ophthalmoparesis, in the differential diagnosis
of a patient presenting with apparently unilateral signs.
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